SCHEMBL6951702

SCHEMBL6951702

CC(C)(C)NS(=O)(=O)c1ccc(C2CC2)cc1Cl

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C8 P10632 2/20 0.41
PTGDR Q13258 1/20 0.41
PTGDR2 Q9Y5Y4 1/20 0.41
ALDH1A1 P00352 2/20 0.40
HSD11B1 P28845 1/20 0.37
LMNA P02545 2/20 0.37
KDM4E B2RXH2 1/20 0.37
MEN1 O00255 1/20 0.37
NPC1 O15118 1/20 0.37
MAPT P10636 1/20 0.37
HPGD P15428 1/20 0.37
RAB9A P51151 1/20 0.37
KMT2A Q03164 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
WDR5 P61964 1/20 0.36
SLC6A2 P23975 4/20 0.36
SLC6A4 P31645 4/20 0.36
SLC6A3 Q01959 4/20 0.36
CNR2 P34972 1/20 0.35
ACLY P53396 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2925439 0.77 TRPV4 (0.47) CYP2C8PTGDRPTGDR2HSD11B1LMNA
SCHEMBL31525797 0.77 TRIM24 (0.50) MEN1KMT2ASMN1; SMN2L3MBTL1
SCHEMBL3407211 0.76 CA1 (0.43) LMNAWDR5SLC6A2SLC6A4SLC6A3
SCHEMBL16261201 0.76 ALDH1A1 (0.46) ALDH1A1HSD11B1LMNAKDM4EMEN1
SCHEMBL2476297 0.75 ACLY (0.45) LMNAWDR5ACLYCYP2D6
SCHEMBL13763741 0.74 ALDH1A1 (0.44) ALDH1A1LMNAKDM4EMEN1NPC1
SCHEMBL6951074 0.74 CA1 (0.49) ALDH1A1HSD11B1LMNAKDM4EMEN1
SCHEMBL16259574 0.72 TRPV4 (0.46) ALDH1A1LMNAKDM4EMEN1NPC1
SCHEMBL16852694 0.71 ALDH1A1 (0.42) ALDH1A1LMNAKDM4EMEN1NPC1
SCHEMBL1794661 0.71 ALDH1A1 (0.41) PTGDRPTGDR2ALDH1A1LMNAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8183293-B2 Phenyl acetic acid derivatives AMGEN INC. (US) 2012-05-22 US disclosed
US-8183293-B2 Phenyl acetic acid derivatives AMGEN INC. (US) 2012-05-22 US disclosed
US-20090275659-A1 Phenyl acetic acid derivatives as inflammation modulators AMGEN INC. (US) 2009-11-05 US disclosed
US-20090275659-A1 Phenyl acetic acid derivatives as inflammation modulators AMGEN INC. (US) 2009-11-05 US disclosed
WO-2009085177-A1 PHENYL ACETIC ACID DERIVATIVES AS INFLAMMATION MODULATORS AMGEN INC. (US) 2009-07-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090275659-A1 Phenyl acetic acid derivatives as inflammation modulators NFKBIA, HCAR2, NFATC1 CYP2C8 1950/4885PTGDR 772/4885PTGDR2 891/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.